Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity.
D001693:Biological Transport, Active; D056486:Chemical and Drug Induced Liver Injury / Q000378:metabolism* / Q000473:pathology; D002839:Chromans / Q000378:metabolism* / Q000633:toxicity*; D003001:Cloning, Molecular; D018076:DNA, Complementary / Q000235:genetics; D004970:Estrone / Q000031:analogs & derivatives* / Q000378:metabolism; D022781:Hepatocytes / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000378:metabolism* / Q000633:toxicity*; D008969:Molecular Sequence Data; D009865:Oocytes / Q000378:metabolism; D027361:Organic Anion Transporters / Q000235:genetics / Q000378:metabolism*; D000077205:Pioglitazone; D011485:Protein Binding; D011809:Quinones / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D045162:Thiazolidinediones / Q000378:metabolism* / Q000633:toxicity*; D000077288:Troglitazone
D002839:Chromans; D018076:DNA, Complementary; D007004:Hypoglycemic Agents; D027361:Organic Anion Transporters; D011809:Quinones; D045162:Thiazolidinediones; D004970:Estrone; D000077288:Troglitazone; C017296:estrone sulfate; D000077205:Pioglitazone